Physiological stability in an indigenous sleep device: a randomised controlled trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 29030386.
- Also identified by DOI 10.1136/archdischild-2017-313512.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To compare overnight oxygen saturation, heart rate and the thermal environment of infants sleeping in an indigenous sleep device (wahakura) or bassinet to identify potential risks and benefits. Randomised controlled trial. Family homes in low socio-economic areas in New Zealand. 200 mainly Māori mothers and their infants. Participants received a wahakura or bassinet from birth. Overnight oximetry, heart rate and temperature at 1 month. Intention-to-treat analysis for 83 bassinet and 84 wahakura infants showed no significant differences between groups for the mean time oxygen saturation (SpO<sub>2</sub>) was less than 94% (0.54 min, 95% CI -1.36 to 2.45) or less than 90% (0.22 min, 95% CI -0.56 to 1.00), the mean number of SpO<sub>2</sub> dips per hour >5% (-0.19, 95% CI -3.07 to 2.69) or >10% (-0.41, 95% CI -1.63 to 0.81), mean heart rate (1.99 beats/min, 95% CI -1.02 to 4.99), or time shin temperature >36°C (risk ratio (RR): 0.63, 95% CI 0.13 to 2.99) or <34°C (RR: 0.89, 95% CI 0.61 to 1.30). A per-protocol analysis of 45 bassinet and 26 wahakura infants and an as-used analysis of 104 infants in a bassinet and 48 in a wahakura found no significant differences between groups for all outcome measures. This indigenous sleep device is at least as safe as the currently recommended bassinet, which supports its use as a sleep environment that offers an alternative way of bed-sharing. Australian New Zealand Clinical Trials Registry: ACTRN12610000993099.
Medical subject headings
- Cultural Characteristics
- Infant Care
- Sleep
- Sudden Infant Death